Position: Neutral

12m Target: $145.00

Catalyst: Upcoming quarterly results and guidance, especially evidence that AIP-driven U.S. commercial growth can remain above 30% while government revenue reaccelerates and operating margins continue to expand.

Primary Risk: The primary risk is valuation compression if growth decelerates even modestly, particularly if commercial deal conversion slows or management guidance suggests AI demand is not scaling fast enough to justify the current premium multiple.

Exit Trigger: Turn more negative if U.S. commercial growth drops below 25% for two consecutive quarters or if management commentary indicates meaningful elongation in AI pilot-to-production conversion cycles without offsetting government strength.

Position: Neutral

12m Target: $145.00

Catalyst: Upcoming quarterly results and guidance, especially evidence that AIP-driven U.S. commercial growth can remain above 30% while government revenue reaccelerates and operating margins continue to expand.

Primary Risk: The primary risk is valuation compression if growth decelerates even modestly, particularly if commercial deal conversion slows or management guidance suggests AI demand is not scaling fast enough to justify the current premium multiple.

Exit Trigger: Turn more negative if U.S. commercial growth drops below 25% for two consecutive quarters or if management commentary indicates meaningful elongation in AI pilot-to-production conversion cycles without offsetting government strength.

Palantir’s current operating profile shows a business still expanding at an unusually high rate for its size. The latest deterministic ratio shows revenue growth of +56.2% year over year, while 2025 annual gross profit was $3.69B on cost of revenue of $789.2M. That translated into a gross margin of 82.4%, operating margin of 31.6%, and net margin of 36.3%.

The market is clearly paying for this demand engine: the live stock price is $160.84 and the market cap is $384.68B as of Mar 24, 2026. On a per-share basis, 2025 revenue was $1.87 per share, with diluted EPS of $0.63. The key point is that Palantir is no longer a small, experimental software name; it is a highly profitable, large-cap software platform whose valuation now depends on whether this growth rate can persist as the revenue base expands.

From an audited filing perspective, the 2025 annual results show real operating scale, not just narrative momentum. Operating income reached $1.41B, free cash flow was $2.100591B, and operating cash flow was $2.134473B. That combination indicates demand is converting into cash, which is essential if the company is to keep funding product development and go-to-market expansion without balance-sheet strain.

The driver is still improving in absolute terms, but the valuation hurdle is rising because the base is much larger than it was a year ago. The audited 2025 balance sheet shows total assets rising from $6.74B at 2025-03-31 to $8.90B at 2025-12-31, while shareholders’ equity increased from $5.42B to $7.39B. That growth in financial capacity supports ongoing product investment and commercial expansion.

The most important evidence that the trajectory remains constructive is the combination of +56.2% revenue growth, 82.4% gross margin, and 46.9% FCF margin. Those are not one-off metrics: they indicate that demand is scaling while unit economics remain excellent. In addition, shares outstanding moved only modestly from 2.37B at 2025-06-30 to 2.39B at 2025-12-31, so dilution has not yet overwhelmed the earnings/cash flow growth.

That said, the trajectory is only “improving” if Palantir can keep growth near current levels. The reverse DCF implies the market is effectively underwriting 47.8% growth; if growth slows materially, the stock can re-rate quickly because the current multiple is already extreme at 86.0x sales and 255.3x earnings.

The upstream inputs to this driver are product adoption, renewal quality, and the pace of enterprise and government procurement conversion. The spine does not disclose a government-versus-commercial split, customer concentration, or AIP-specific monetization, so the exact mix of demand sources is . What is verified is that the result of those upstream inputs is strong top-line growth—+56.2%—paired with elite margins and cash generation.

Downstream, sustained revenue growth feeds directly into operating leverage, free cash flow, and ultimately equity duration. In 2025, Palantir produced $1.41B of operating income and $2.100591B of free cash flow, while equity rose to $7.39B. If the demand engine stays hot, it can support continued reinvestment without balance-sheet stress; if demand slows, the multiple is vulnerable because the equity is priced as a long-duration compounder.

The valuation consequence is straightforward: every incremental proof point of repeatable demand helps defend the current premium, while any evidence of deceleration would flow through to the earnings multiple first and the cash-flow multiple second. That is why this pane treats demand durability—not margin alone—as the key value driver.

1) Q1 2026 earnings / guidance update (May 6, 2026) — This is the highest-probability, highest-impact catalyst because PLTR’s valuation is highly guidance-sensitive. Probability is 95%, and I estimate a price impact of roughly -$8 to +$12/share depending on whether management confirms continued 40%+ growth and sustained margin expansion. With EV/Revenue 85.6 and a live price of $137.97, even a small change in forward confidence can move the stock materially.

2) Q2 2026 earnings / backlog and commercial mix commentary (Aug 5, 2026) — Probability 92%, estimated impact -$7 to +$10/share. This matters because the market is no longer just rewarding “beat and raise”; it wants evidence that growth is broadening beyond the first half’s momentum. If management shows strong conversion in U.S. commercial and government demand, the stock can extend; if commentary turns cautious, the premium multiple is vulnerable.

3) AIP / product rollout and production-deployment proof point (soft date mid-2026) — Probability 55%, estimated impact -$5 to +$9/share if it is tied to named customer adoption and recurring spend. This is the most important product catalyst because PLTR’s bull case depends on experimentation turning into durable revenue. Without evidence of monetized deployment, product news is mostly narrative and the valuation will likely revert to earnings execution alone.

• Ranking basis: probability × expected dollar impact, not simply event importance.
• Key point: earnings dominate because the current multiple leaves little room for ambiguity.

In the next 1–2 quarters, the stock will likely trade on whether Palantir can keep revenue growth near the +56.2% 2025 level while preserving high-quality profitability. The most important threshold is not simply “beat consensus,” but whether management can keep signaling that growth remains materially above 30% with operating leverage intact. I would watch for gross margin staying above 80%, operating margin holding above 25%, and free cash flow remaining above $1.5B annualized if the run-rate continues.

On the demand side, the key missing metrics are U.S. commercial growth, U.S. government growth, backlog/RPO, and customer expansion. If the company can show that the 2026 revenue per share trajectory is moving toward the institutional estimate of $2.55 for 2026 while EPS trends toward $1.15, the market may keep underwriting the premium. If revenue growth slips meaningfully below the 40% area, or if management becomes cautious on forward bookings, the stock’s $160.84 price will look increasingly disconnected from the $76.54 base DCF value.

• Thresholds to watch: growth rate, margin durability, cash conversion, and guidance tone.
• Primary read-through: the next two quarters decide whether PLTR is a durable compounder or a high-multiple momentum name.

Q1 2026 earnings / guidance update: probability of material market-moving execution is 95%, timeline May 6, 2026, and evidence quality is Hard Data because the event is confirmed by the earnings cadence even though forward numbers are not yet known. If it does not materialize as a positive catalyst, the likely outcome is not a business failure; it is valuation compression because the stock already trades at 255.3x P/E and 85.6x EV/revenue.

AIP / product monetization proof point: probability 55%, expected timeline mid-2026, and evidence quality is Soft Signal because product momentum is inferred from strategic positioning rather than disclosed operating metrics. If it fails to appear, the bear interpretation is that product enthusiasm is not converting into measurable revenue acceleration, which would leave the thesis dependent on earnings alone.

Government/commercial demand acceleration: probability 60%, timeline next 2 quarters, and evidence quality is Thesis Only in this pane because key operating disclosures such as backlog, customer count, and segment mix are missing. If this does not materialize, PLTR can still remain profitable, but the market may re-rate the stock toward the $76.54 DCF base value instead of paying for a continued growth premium.

Overall value trap risk: Medium-High. The business quality is real, but the current price already discounts a very strong future state, so the stock can behave like a value trap if the catalyst stream becomes merely adequate rather than exceptional.

The DCF anchors on the company’s audited 2025 base: $3.69B revenue, $1.63B net income, and $2.10B free cash flow. I use a 5-year projection period, 6.0% WACC, and 4.0% terminal growth, which is intentionally below the reverse-DCF implied 5.1% terminal rate and far below the market’s growth expectations. That gap matters because PLTR’s current multiple only makes sense if growth stays extraordinary for longer than the base case assumes.

On margins, I do not assume full perpetual expansion from the current 31.6% operating margin and 46.9% FCF margin. Palantir has a strong software-style economic model, but its competitive advantage is best described as a mix of capability-based and position-based advantages rather than a pure customer-captive utility moat. Because the spine does not show segment mix, customer retention, or backlog metrics, I only justify modest margin durability: operating margin stays high near current levels in the near term, then mean-reverts slightly toward a still-premium mature-software level rather than expanding indefinitely. SBC at 15.3% of revenue is the main reason to avoid a heroic long-run margin assumption.

Using these assumptions, I compute a $76.54/share DCF fair value. That is well below the live market price of $160.84, so the market is effectively underwriting a scenario closer to the reverse DCF than the audited base case.

The reverse DCF implies 47.8% growth and a 5.1% terminal growth rate, which is a very aggressive underwriting standard for a company already valued at $384.68B market cap. Those inputs are materially richer than the base DCF, which uses 6.0% WACC and 4.0% terminal growth and still lands at only $76.54/share. Put differently, the market is not just assuming Palantir keeps growing; it is assuming the company keeps compounding at a platform-scale rate for long enough that the present value of those cash flows overwhelms today’s price.

My judgment is that the implied expectations are not unreasonable for a top-decile AI software winner, but they are too demanding to treat as a base case. The reason is simple: the company already posted 56.2% revenue growth, 31.6% operating margin, and 46.9% FCF margin in 2025, so the starting point is excellent; however, the current multiple of 255.3x earnings and 86.0x sales leaves little room for deceleration. If growth remains above 40% while SBC trends down from 15.3% of revenue, the reverse DCF becomes more plausible. If not, the market price is likely vulnerable to a sharp re-rating before the business fundamentals weaken materially.

Palantir’s audited FY2025 income statement shows a business that is no longer merely scaling revenue — it is translating growth into meaningful profit. Revenue inferred from EDGAR line items was $4.48B, with $3.69B of gross profit, $1.41B of operating income, and $1.63B of net income. That works out to a 82.4% gross margin, 31.6% operating margin, and 36.3% net margin. The quarterly path also improved across 2025: gross profit rose from $710.9M in Q1 to $973.8M in Q3, while operating income expanded from $176.0M to $393.3M, demonstrating operating leverage as the top line scaled.

Relative to peers in enterprise software, the margin profile is unusually strong. The institutional peer set in the spine includes Oracle and SAP, both durable software franchises, yet Palantir’s audited margins are the more striking numbers in this dataset. The key difference is that Palantir is combining high growth with high profitability: revenue growth was +56.2% YoY, while net income remained positive and accelerated through the year. That is the kind of combination investors normally pay up for — but at 255.3x P/E and 86.0x P/S, the market is already discounting sustained execution well beyond a normal software re-rate.

• Operating leverage: operating income rose from $176.0M in Q1 to $393.3M in Q3.
• Peer context: profitability is stronger than typical high-growth software comparables, but the stock’s valuation is much richer than peer averages.
• Interpretation: margins are now a core bull case input, not a future hope.

Palantir’s FY2025 balance sheet remains exceptionally conservative. The company ended the year with $1.42B in cash and equivalents, $8.36B in current assets, $1.18B in current liabilities, $1.41B in total liabilities, and $7.39B in shareholders’ equity. The deterministic ratio set shows a 7.11 current ratio, 0.0 debt-to-equity, and 0.19 total liabilities-to-equity. That is a very low-risk capital structure and leaves plenty of room to invest without needing external financing.

There is no covenant stress evident in the data provided, and interest coverage is not a meaningful constraint here because debt is effectively zero in the authoritative ratios. The quarter-to-quarter cash balance moved from $993.5M at 2025-03-31 to $929.5M at 2025-06-30 and then up to $1.62B at 2025-09-30 before finishing FY2025 at $1.42B. That volatility is not a red flag by itself because liquidity remained ample throughout, but it does show cash is being actively deployed rather than simply accumulating passively.

• Debt: no meaningful debt burden is visible.
• Liquidity: current ratio of 7.11 is far above distressed or even normal software levels.
• Asset quality: goodwill is minimal historically, suggesting little acquisition-related balance sheet fragility.

Cash flow quality is one of the strongest parts of the Palantir story. FY2025 operating cash flow was $2.13B and free cash flow was $2.10B, producing a 46.9% free cash flow margin and essentially confirming that the reported profits are backed by cash generation. Capex was only $33.9M for the year, which is just 0.8% of inferred revenue of $4.48B. D&A was $26.1M, also modest relative to scale, reinforcing the capital-light nature of the model.

Working capital appears manageable given the high current ratio and the fact that current assets of $8.36B materially exceed current liabilities of $1.18B. The company’s cash conversion profile is notably strong: cash from operations nearly matched free cash flow, indicating that capex is not consuming a large share of internally generated cash. The main watch item is not cash burn, but whether high SBC and growth investments begin to dilute per-share economics even while aggregate cash flow remains robust.

• FCF conversion: FCF / net income is roughly 129% using FY2025 figures.
• Capex intensity: capex was only 0.8% of revenue.
• Quality signal: OCF and FCF are tightly aligned, which usually supports earnings credibility.

Palantir’s capital allocation profile is dominated by reinvestment rather than dividends or buybacks. No dividend is indicated, and the company continues to allocate significant expense to R&D, which was $557.7M in FY2025 or 12.5% of revenue. That level of reinvestment is consistent with a product-driven software company still expanding its platform and customer footprint, and it helps explain why operating leverage can continue to improve even at scale.

The effectiveness of this strategy is visible in the reported income statement: Palantir still produced $1.41B of operating income and $2.10B of free cash flow while maintaining a debt-free capital structure. However, stock-based compensation remains the main offset to value creation. SBC was 15.3% of revenue, and diluted shares at 2025-12-31 were 2.57B versus 2.39B shares outstanding, which means per-share dilution is still a meaningful drag even when the business itself is generating strong cash. That makes capital allocation effective at the enterprise level, but not yet clean at the per-share level.

• R&D intensity: 12.5% of revenue, supporting product reinvestment.
• Buybacks/dividends: no dividend signal in the spine; no buyback data provided.
• Key offset: SBC at 15.3% of revenue is the primary dilution risk.

Palantir’s 2025 cash generation was strong enough to fund internal investment without depending on debt or external equity. The company produced $2.13B of operating cash flow and $2.10B of free cash flow, while capex was only $33.9M and R&D was $557.7M (12.5% of revenue). That combination indicates the dominant use of cash is still reinvestment in the product/platform rather than direct shareholder distribution.

Relative to mature software peers such as SAP, Oracle, and IBM, Palantir is notably more growth-oriented and less return-of-capital oriented. The spine provides no evidence of dividends or buybacks, while share count rose from 2.37B at 2025-06-30 to 2.39B at 2025-12-31, suggesting that any implicit allocation to equity compensation/dilution has not yet been offset. The practical result is a waterfall that appears weighted toward R&D > cash accumulation > shareholder returns, with little visible debt paydown need because leverage is essentially zero.

• R&D: highest visible allocation at 12.5% of revenue
• Capex: minimal at $33.9M, consistent with an asset-light model
• Debt paydown: not a meaningful use; debt/equity is 0.0
• Dividends/buybacks: no evidence of active distribution policy in the spine
• Cash accumulation: cash still substantial at $1.42B year-end, but down from $2.10B

The key portfolio implication is that Palantir has capacity to become a shareholder-return story later, but it is not behaving like one today. The absence of distributions is not a liquidity constraint; it is a management choice.

Palantir’s shareholder return profile is overwhelmingly a function of price appreciation, because the provided spine shows no dividend stream and no disclosed buyback program. At a market price of $137.97 and market cap of $384.68B, the stock is pricing in exceptionally high future growth, which means TSR has been driven far more by valuation expansion than by direct capital returns. That matters because when a stock trades at a P/E of 255.3 and P/S of 86.0, marginal capital-allocation errors can overwhelm otherwise strong operating performance.

Compared with the broader software group and established cash-returners like Oracle, IBM, and SAP, Palantir is still in the phase where management is effectively reinvesting every dollar of internally generated cash. The company’s ROIC of 23.3% and ROE of 22.0% show that retained capital has been productive so far, but the lack of direct cash distributions means outside shareholders are relying on continued execution and multiple support. The estimated 0.00% dividend yield and 2.39B shares outstanding reinforce that this is a compounding story, not a harvest story.

• Dividends: 0% contribution based on available data
• Buybacks: 0% visible contribution; no repurchase disclosure provided
• Price appreciation: dominant TSR driver
• Peer comparison: less mature distribution profile than SAP/Oracle/IBM

The main takeaway for investors is that Palantir must keep beating lofty expectations for TSR to remain attractive; direct return of capital is not currently doing any work.

Palantir’s 2025 revenue expansion appears to be driven by three quantifiable forces visible in the audited numbers, even though the spine does not provide a formal segment split. First, the company generated $4.47B of implied revenue in 2025, up 56.2% YoY, which is the clearest evidence that the core platform is taking share and/or expanding within existing customers. Second, gross profit reached $3.69B on just $789.2M of cost of revenue, indicating that the business mix is favorable and incremental revenue is high-margin. Third, operating income of $1.41B and free cash flow of $2.10B show the growth is not being bought with excessive operating spend; R&D was $557.7M, or 12.5% of revenue, which suggests product investment is still disciplined relative to the scale of expansion.

The practical inference is that the main “drivers” are not a single disclosed geography or product line, but rather the combination of platform adoption, high gross retention/expansion economics implied by the margins, and a cost structure that allows operating leverage to compound. The one non-EDGAR clue in the evidence set — a reported Q4 2023 commercial revenue surge — is directionally consistent with this scaling narrative, but it remains secondary to the audited 2025 results.

Palantir’s unit economics are exceptional on the evidence available. The company posted 82.4% gross margin, 31.6% operating margin, and 46.9% free cash flow margin in 2025, which tells you that each incremental dollar of revenue is leaving a very large contribution after delivery costs and still generating substantial cash after operating expense. With $789.2M of cost of revenue against $3.69B of gross profit, the platform appears to have strong pricing power and/or efficient delivery economics at scale.

The cost structure also looks disciplined. R&D was $557.7M, or 12.5% of revenue, which is meaningful enough to support product development but not so high that it overwhelms operating leverage. For a software business, that profile suggests customer value is high enough to support premium pricing, while the combination of $2.13B operating cash flow and $2.10B free cash flow implies the company is already monetizing its installed base with limited capital intensity. LTV/CAC cannot be calculated from the spine because customer acquisition spend and cohort data are not disclosed, but the earnings-to-cash conversion suggests payback is not the binding constraint at the corporate level.

Using the Greenwald framework, Palantir fits best as a Position-Based moat candidate, with some capability-based reinforcement. The strongest captivity mechanism visible from the spine is likely switching costs combined with brand/reputation and a large-scale deployment footprint: a customer that has already integrated the platform into operations may face meaningful disruption if they tried to replace it, and the company’s 82.4% gross margin and 23.3% ROIC indicate it is extracting value from a platform that scales unusually well. The exact customer-captivity mechanism is not disclosed in the data spine, so this is an inference, but it is consistent with the business economics.

Durability looks moderate-to-strong, but not permanent. If a new entrant matched the product at the same price, the key test would be whether they could capture the same demand immediately; the observed profitability and cash generation imply the answer is probably no for many customers, because the installed-base and integration burden likely matter. I would estimate moat durability at 5-7 years before meaningful erosion, assuming execution remains strong and the company continues to compound operational complexity into customer stickiness. The main caution is that this is still a software market with credible incumbents and AI-native challengers, so the moat must be refreshed through product velocity rather than relied upon passively.

Palantir’s technology stack looks differentiated by workflow integration depth rather than by commodity infrastructure. The FY2025 numbers show the business sustaining 82.4% gross margin, 31.6% operating margin, and 46.9% FCF margin, which is consistent with software that becomes embedded in customer operations and is not easily swapped out once deployed.

The core moat appears to be the ability to turn data integration, operational decisioning, and application-layer workflows into repeatable enterprise deployments. That matters because it suggests the proprietary value is concentrated in the platform architecture and implementation know-how, while underlying compute and hosting are comparatively commoditized. The company’s low capital intensity — $33.9M of CapEx in 2025 versus $26.1M of D&A — reinforces that this is a software-led stack, not an asset-heavy technology model.

• Proprietary: data ontology / integration workflows / mission-critical deployment patterns.
• Commodity: cloud infrastructure, storage, and general-purpose compute.
• Integration depth: high, as evidenced by profitability and scaling without commensurate capital intensity.

From an investor perspective, the important question is not whether the technology is sophisticated — it is — but whether that sophistication can continue to translate into customer lock-in and pricing power as the installed base expands. The financials currently say yes, but the valuation already discounts a long runway of continued execution.

Palantir spent $557.7M on R&D in FY2025, equal to 12.5% of revenue, indicating a meaningful but disciplined investment posture. Quarterly R&D moved from $134.9M in Q1 2025 to $144.2M in Q3 2025, while gross profit expanded from $710.9M to $973.8M over the same periods, so product investment did not outrun monetization.

The spine does not disclose named launch dates or program-level milestones, so any detailed launch calendar is . However, the financial pattern implies that the pipeline is focused on iterative platform expansion, likely centered on AI-enabled workflow layers, implementation tools, and deployment automation rather than a large number of stand-alone products. This is important because it suggests R&D is being allocated toward platform breadth and deeper customer adoption instead of speculative moonshots.

• Near-term emphasis: platform enhancement and enterprise deployment tooling.
• Revenue impact: not separately disclosed; inferred to be embedded in FY2025 growth of 56.2%.
• Capital allocation: R&D is sizeable but supported by $2.10B free cash flow and strong liquidity.

In short, the pipeline looks healthy, but investors should treat detailed product-launch expectations cautiously because the available disclosure does not identify specific modules, timing, or ARR contribution.

The provided spine does not disclose a patent schedule, IP count, or litigation docket, so the patent count remains . What is observable is a moat built less on formal patent density and more on software architecture, trade secrets, and accumulated deployment know-how. The financial profile — 82.4% gross margin, 23.3% ROIC, and minimal historical goodwill of $37.9M in 2022 — is more consistent with organic product differentiation than acquisition-driven IP assembly.

Estimated protection duration for this moat is best viewed as multi-year and self-reinforcing, but not legally quantifiable from the provided facts. The defense comes from embedded workflows, customer switching costs, and platform integration rather than from a single blocking patent. Because the company’s model is software-led and capital-light, the most durable protection likely comes from accumulated implementation complexity and domain-specific data models.

• Patent count:
• Trade secrets / know-how: likely material, but not quantified in the spine.
• Estimated protection: multi-year; exact duration not disclosed.

For investors, that means the moat is real but harder to evidence through standard patent metrics. The key monitoring question is whether Palantir continues to convert its know-how into customer retention and new deployments faster than large incumbents can replicate similar features.

The hard risk in PLTR’s supply chain is not the presence of a large physical vendor concentration; it is the absence of disclosure around the software stack underneath the business. The data spine does not disclose key supplier count, top vendor concentration, inventory, or purchase commitments, so the company could still be exposed to a small number of hyperscalers, data providers, or implementation partners without that showing up in audited financial statements.

What we can say with confidence is that the company’s operating model is extremely asset-light: FY2025 CapEx was only $33.9M, D&A was $26.1M, gross margin was 82.4%, and free cash flow was $2.10B. That profile makes a classic single-source parts failure unlikely; instead, the single points of failure are more likely to be cloud availability, customer implementation capacity, or third-party data access. In other words, the concentration risk is likely in the invisible vendor layer, not in physical logistics.

The provided spine does not break out sourcing by country, region, or data-center footprint, so any geographic exposure must be treated as . That said, the balance sheet and income statement suggest the business is not dependent on heavy manufacturing, imported components, or tariff-sensitive BOM inputs. The most relevant geographic risks are therefore likely jurisdictional: cloud-region availability, government procurement rules, and data localization constraints rather than port congestion or customs delays.

Using the available data, I would assign a 3/10 geographic risk score on an analyst-estimate basis only. The reason is that PLTR’s FY2025 model generated $3.69B of gross profit on just $789.2M of cost of revenue, implying limited exposure to physical trade lanes. Still, if a large share of compute or data services is concentrated in a single country or hyperscaler region, the effect could be material even though the company does not disclose it here.

STREET SAYS: Palantir can sustain a premium multiple because the business is already generating audited 2025 revenue growth of 56.2%, gross margin of 82.4%, operating margin of 31.6%, and diluted EPS of $0.63. The institutional survey’s 3-5 year EPS view of $2.20 suggests the Street-like expectation set is for substantial per-share compounding from here, not just stabilization.

WE SAY: The current price of $160.84 is well ahead of our deterministic DCF fair value of $76.54, and even above the model’s base-case range implied by the Monte Carlo median of $52.12. We think the market is pricing a far more aggressive revenue and EPS trajectory than the audited 2025 run-rate alone supports, so our stance is Neutral-to-Short on valuation despite strong operating quality.

Key numbers: 2025 gross profit was $3.69B, operating income was $1.41B, net income was $1.63B, and free cash flow was $2.10B. Those are exceptional fundamentals, but they do not, by themselves, justify the current multiple of 255.3x earnings and 86.0x sales unless growth remains elevated for many years.

Recent revisions appear to be skewed upward on EPS and generally supportive of the growth story, but the evidence set is too sparse to quantify a full Street revision history with confidence. The key visible anchor is the institutional survey, which now points to $2.20 in 3-5 year EPS versus $0.63 audited 2025 diluted EPS, implying that forward estimates are being lifted by expectations for continuing operating leverage.

From a valuation standpoint, however, upward EPS revisions do not automatically translate into upside if the multiple remains constrained by the current 255.3x P/E and 86.0x P/S. In other words, the revision trend may be positive, but the stock can still be fragile if price already discounts the better part of those improvements.

DCF Model: $77 per share

Monte Carlo: $52 median (10,000 simulations, P(upside)=10%)

Reverse DCF: Market implies 47.8% growth to justify current price

PLTR’s earnings quality looks strong because the company is converting growth into real cash and reported profit. Annual operating income reached $1.41B, net income reached $1.63B, and free cash flow was $2.100591B with a 46.9% FCF margin. Those three metrics moving together reduce the risk that earnings are being driven mainly by non-cash accounting items.

The balance sheet and capital intensity also support quality. CapEx was only $33.9M in 2025 versus D&A of $26.1M, while current assets of $8.36B dwarfed current liabilities of $1.18B. R&D remained elevated at $557.7M or 12.5% of revenue, which suggests management is still investing rather than simply harvesting margin.

• Beat consistency: quarter-by-quarter beat data not provided in the spine.
• Accruals vs cash: operating cash flow $2.134473B exceeded net income $1.63B on the annual basis.
• One-time items: no detailed non-recurring item schedule provided.

There is no explicit 90-day analyst revision tape in the Data Spine, so the direction and magnitude of recent estimate changes are . The only forward datapoints available are the institutional survey estimates of $0.60 EPS for 2025 and $1.15 EPS for 2026, alongside revenue per share rising from $1.85 in 2025 to $2.55 in 2026.

What can be inferred is that expectations remain constructive but not explosive relative to current trading levels. With the stock at $160.84, the market is already discounting much more than the survey’s near-term EPS path, so any revisions that slow even modestly would likely matter disproportionately. If future revisions continue to move upward, the main thing to watch is whether the increase comes from revenue scale, margin expansion, or both.

• Revised metrics: consensus EPS, revenue, and margin estimates are not supplied quarter by quarter.
• Direction: no 90-day revision series available.
• Magnitude: institutional EPS rises from $0.60 to $1.15 over 2025E-2026E imply higher medium-term confidence, but not a precise revision trend.

Management credibility appears high based on the audited 2025 trajectory: operating income improved from $176.0M in 2025-03-31 [Q] to $393.3M in 2025-09-30 [Q], and full-year operating income reached $1.41B. Net income and cash flow also strengthened in parallel, which is the cleanest evidence that messaging is aligned with execution rather than merely promotional.

There is no restatement history or documented goal-post moving in the Data Spine, and the balance sheet continues to strengthen with equity rising to $7.39B. The main caveat is that quarter-level guidance ranges are not provided, so direct guidance accuracy cannot be scored. Still, the combination of sustained profitability, high cash conversion, and disciplined R&D spending suggests management has been consistent across quarters.

• Meeting commitments: explicit guidance/commitment data not included.
• Messaging consistency: supported by steadily rising profit, cash flow, and equity.
• Restatements: none identified in the spine.

The next print should be judged first on whether PLTR can preserve its current growth and margin combination. The most important datapoints are revenue growth, operating margin, and free cash flow conversion, because the company already screens at 82.4% gross margin, 31.6% operating margin, and 46.9% FCF margin. Those are high bars; even a small slowdown can matter if the market continues to price the stock at 86.0x sales and 255.3x earnings.

Consensus expectations for the next quarter are because no forward quarter consensus is included in the spine. Our estimate is that the key test will be whether operating income grows faster than revenue again, with R&D staying near the recent quarterly band of $134.9M to $144.2M. The datapoint that matters most is whether management can continue to show revenue durability without margin compression.

• Primary watch items: revenue, operating margin, FCF, and R&D intensity.
• Specific datapoint: quarterly operating income versus quarterly revenue growth.
• Consensus: not provided.

The spine does not provide live alternative-data series such as job postings, web traffic, app downloads, patent filings, or social sentiment, so those channels remain here. That said, the audited financials and deterministic ratios already point to a strong operating signal: revenue growth is +56.2%, gross margin is 82.4%, and free cash flow margin is 46.9%, which is the kind of core operating strength alternative data would normally need to corroborate rather than contradict.

From an analyst perspective, the absence of granular alt-data is itself a constraint. Without a verified trend in hiring velocity, branded search, or usage intensity, we cannot separately confirm whether growth is broad-based or concentrated in a narrow set of contracts. If future alt-data shows slowing job postings, flattening web traffic, or weaker developer activity while revenue still grows at a high rate, that would be a warning that the current financial signal may be decelerating ahead of the reported numbers.

• Verified signal: strong operating leverage and cash conversion.
• Missing signal: job postings / web traffic / app / patent data are .
• Methodology note: this pane relies on SEC EDGAR and deterministic ratios; no third-party alt-data feed is included in the spine.

Institutional survey inputs suggest the stock is viewed as a high-quality but not low-risk compounder: Financial Strength A, Safety Rank 3, Timeliness Rank 2, and Price Stability 5. That combination implies investors are willing to pay for the story, but they are also expecting meaningful volatility and are not treating the name as a defensive software holding.

The institutional 3–5 year EPS estimate of $2.20 and target range of $130.00–$195.00 are important because they bracket the current live price of $137.97. In other words, the survey is broadly constructive but not wildly Long; it supports the view that the market is already discounting a lot of good news, and that incremental upside likely depends on sustained execution rather than a sudden sentiment rerating.

• Cross-check: survey target range overlaps the current price, which is consistent with an already-full valuation.
• Risk read: price stability of 5 suggests this is not a low-volatility ownership profile.
• Interpretation: sentiment is positive on quality, cautious on valuation.

Palantir is extremely liquid by dollar trading standards, but the Data Spine does not provide the underlying tape statistics needed to quote average daily volume, bid-ask spread, or a quantified days-to-liquidate estimate. Because the live market cap is $384.68B and shares outstanding are 2.39B, the stock is likely to support institutional-sized flows, yet that inference remains directional rather than measured without the missing volume series.

The key practical point is that any large-block estimate should be treated cautiously until market data are supplied. The report can state only that institutional turnover ratio and market impact for a $10M position are from the Data Spine, so execution conclusions should not be over-read from this pane alone.

• Average daily volume:
• Bid-ask spread:
• Institutional turnover ratio:
• Days to liquidate $10M:
• Market impact estimate:

The Data Spine does not include the price-history series required to calculate factual 50 DMA / 200 DMA positioning, RSI, MACD, or support and resistance levels. Accordingly, those items must remain in this pane rather than being inferred from the live price alone.

What can be said factually is limited to the current price of $160.84 as of Mar 24, 2026, along with the institutional survey’s Technical Rank of 3 on a 1-to-5 scale. That rank suggests the tape is not being flagged as especially strong or especially weak by the external survey, but it is not a substitute for the underlying technical indicators requested here.

• 50/200 DMA position:
• RSI:
• MACD signal:
• Volume trend:
• Support / resistance:

We do not have a live option chain, so 30-day IV, IV rank, and realized-volatility readings are . That said, the stock’s current setup strongly suggests that the market is pricing a premium for future growth persistence rather than balance-sheet risk. Palantir’s audited 2025 results show gross margin of 82.4%, operating margin of 31.6%, and free cash flow margin of 46.9%, which are the kind of fundamentals that typically support rich call demand and persistent event volatility.

What matters for the expected move is the gap between the market price and intrinsic value. The live share price is $137.97, while the deterministic DCF fair value is $76.54 and the Monte Carlo median is $52.12. Even the Long DCF case of $172.20 is only slightly above spot, which implies the options market would likely need to charge for a materially elevated move profile into earnings if that fair-value framework is the anchor. In plain English: the stock can stay expensive, but the market is already paying for a lot of perfection.

• Fundamental quality is strong enough to justify persistent upside interest.
• Valuation is so stretched that even modest disappointment can compress multiple-sensitive calls.
• Without a realized-volatility series, we cannot confirm whether IV is rich or cheap versus history.

No strike-by-strike tape, open interest, or block-trade feed was supplied, so specific unusual options trades, strikes, expiries, and institutional sweeps are . The strongest inference we can make is structural: this is a name where traders are likely to express views through calls, call spreads, and event-driven straddles because the equity trades on a high-growth narrative and a very high valuation multiple. That is consistent with the observed gap between the live price of $160.84 and the DCF base case of $76.54.

From a flow perspective, the lack of debt and the presence of $2.100591B of free cash flow reduce the odds of traditional downside “panic put” demand tied to financing risk. Instead, any notable options activity would likely center on earnings, guidance, and valuation re-rating. If you later see concentrated call open interest around a forward expiry near earnings, especially strikes above spot, that would reinforce the view that the market is still paying up for upside continuation rather than just hedging a collapse.

• Specific large trades:
• Notable OI strikes/expiries:
• Institutional positioning signal: likely growth-duration positioning, but not directly observable from current data.

Short interest percentage of float, days to cover, and borrow-cost trend are because no lending or short-interest feed was provided. Based on the company’s profile, though, the squeeze setup would be less about distress and more about valuation risk. Palantir has 0.0 debt-to-equity, a 7.11 current ratio, and strong cash generation, so shorts would likely be positioning against multiple compression rather than against insolvency.

That distinction matters. A high-quality, cash-generative software name can stay expensive for a long time, but if short interest is elevated and borrow is tight, the stock can still experience squeeze-like upside around earnings or guidance. In the absence of actual borrow and SI data, the prudent classification is Medium squeeze risk: not because of leverage or default, but because the valuation is already extreme at 255.3x P/E and any positive surprise could force rapid covering.

• SI a portion of float:
• Days to cover:
• Borrow cost trend:
• Squeeze risk assessment: Medium, conditional on elevated short positioning.

Because live IV data are missing, we cannot compute a precise next-earnings expected move from the chain. Still, the model outputs provide a useful anchor: the DCF bull case is $172.20, which is only about 7.0% above the current price of $160.84. That suggests the market does not need heroic upside to remain supported, but it also means a standard earnings move could easily be large enough to matter if the stock is already priced for near-perfect execution.

Comparing valuation anchors, the current price is 2.10x the DCF fair value of $76.54 and 3.09x the Monte Carlo median of $52.12. That is a classic setup where implied volatility often stays elevated into catalysts even if realized volatility later compresses after the report. If you later supply an earnings date and chain, we would translate that directly into a dollar move and probability-of-exceeding-strike framework.

• Expected move into earnings:
• Large-move probability: directional risk is high, but exact probability cannot be computed without IV.
• Realized vol comparison:

Palantir’s derivatives profile should be read through the lens of crowding in a premium multiple, not through distress. The company generated $2.134473B of operating cash flow and $2.100591B of free cash flow in 2025, while revenue growth remained +56.2%. Those are excellent operating facts, but they are also exactly the kind of facts that can be overbid in an options market when investors extrapolate growth far into the future.

That makes the implied-volatility question asymmetrical. If IV is high, it may be justified by the magnitude of the valuation gap; if IV is lower than expected, it could still rise quickly on any guidance that extends the growth runway. The takeaway for portfolio management is simple: the stock is likely to trade as a catalyst-heavy compounder, where options are priced around narrative persistence and earnings execution rather than balance-sheet repair.

• 30-day IV vs. 1-year mean:
• Percentile rank:
• Expected move comparison to realized vol:

1) Valuation re-rating risk. Probability high; price impact -$90 to -$120 if the market migrates toward the DCF base value of $76.54 or the Monte Carlo median of $52.12. The current P/E of 255.3 and EV/Revenue of 85.6 leave almost no room for disappointment, and the risk gets closer if revenue growth slips below the current +56.2% pace.

2) Growth deceleration from a very large base. Probability high; price impact -$60 to -$100. The company has already reached roughly $4.48B of annual revenue, so maintaining close to 50% growth becomes harder as the base expands. The threshold that matters is sustained growth below 35% for multiple quarters, which would challenge the reverse DCF assumption of 47.8% implied growth.

3) Dilution / SBC creep. Probability high; price impact -$25 to -$45. Stock-based compensation is 15.3% of revenue and shares outstanding increased from 2.37B to 2.39B across 2025. If share count keeps climbing while the valuation multiple compresses, per-share value creation weakens even if revenue remains strong.

4) Competitive contestability in enterprise software. Probability medium; price impact -$30 to -$70. A competitor could trigger a price war or product substitution if buyer willingness to pay for bespoke deployments weakens. This is especially important because no customer concentration, win-rate, or NDR data are provided here, so the moat cannot be independently stress-tested.

5) Operating margin mean reversion. Probability medium; price impact -$20 to -$50. The latest operating margin is 31.6%, but sustaining that level may require continued heavy R&D and sales execution. If margins fall toward the mid-20s, the market can revalue the business as a strong software company rather than an exceptional one.

The bear case is that PLTR remains a very good business but no longer qualifies as a hyper-growth rarity, and the valuation snaps back toward a more normalized software-multiple framework. In that scenario, the stock does not need a collapse in fundamentals; it only needs revenue growth to decelerate from +56.2% toward the mid-30% range, while the market re-rates the company from 85.6x EV/Revenue to something closer to a premium-but-plausible software multiple. Our bear value is $34.63, implying -78.5% downside from $160.84.

The path is straightforward: first, investors notice that the reverse DCF already requires 47.8% implied growth and 5.1% terminal growth, which is a very demanding setup for a company already producing approximately $4.48B of annual revenue. Second, if SBC remains above 15% of revenue and share count keeps rising beyond 2.39B, per-share economics lag headline growth. Third, if competitive pressure lowers pricing power or slows enterprise adoption, the market can move quickly from rewarding execution to punishing ambiguity. The bear thesis is therefore not about insolvency or even near-term profitability; it is about the market concluding that the current price is pricing in an execution path that is too perfect to persist.

The Long narrative says PLTR is a durable, compounding software platform, but the numbers say the stock is already priced for exceptional perfection. The clearest contradiction is that the company generated audited 2025 operating income of $1.41B and net income of $1.63B, yet the market still values it at 255.3x P/E and 86.0x P/S. That means profitability alone is not what is being bought; investors are implicitly paying for a continuation of very high growth.

There is also a mismatch between the “quality” story and dilution. The company produced a strong 46.9% FCF margin, but SBC is still 15.3% of revenue and diluted shares stood at 2.57B at 2025-12-31 versus 2.37B at 2025-06-30 on the share count data provided. The bull case must reconcile strong cash generation with continuing per-share dilution. Finally, the moat narrative is hard to stress-test because the spine contains no customer concentration, NDR, or segment mix; the market may be assuming broadening adoption, but those numbers are currently .

Balance-sheet risk is negligible. Current ratio is 7.11, debt to equity is 0.0, and total liabilities to equity are only 0.19. That means the company can absorb cyclical softness or a slow sales year without needing external capital, which materially lowers permanent-capital-loss risk from insolvency.

Profitability and cash generation are already real. Gross margin is 82.4%, operating margin is 31.6%, and free cash flow is $2.100591B. Those figures make it easier for management to keep investing through a slowdown without destroying the franchise.

Product and R&D investment remain meaningful. R&D expense is $557.7M, or 12.5% of revenue, which supports product evolution and could defend the moat if competitors try to close the gap. The key question is whether this spending converts into broader repeatable adoption rather than bespoke wins. If it does, the thesis can survive even with a moderated valuation; if it does not, the risk of multiple compression rises materially.

Palantir scores well on the business-quality side of the Buffett checklist, but the price remains the main objection. The company is highly understandable as a software/data platform business with very strong 2025 economics: gross margin 82.4%, operating margin 31.6%, net margin 36.3%, and free cash flow $2.10B. That combination supports a moat-like profile, especially because CapEx was only $33.9M in 2025 and the balance sheet is exceptionally conservative with 0.0 debt/equity and 7.11 current ratio.

On the other hand, Buffett’s “sensible price” test is clearly not met at the current quote of $137.97. A P/E of 255.3, P/S of 86.0, and DCF fair value of $76.54 argue that investors are paying for a multi-year perfection case, not a margin-of-safety investment. The qualitative scores below reflect that tension:

• Understandable business: 4/5
• Long-term prospects: 4/5
• Management and capital allocation: 3/5
• Sensible price: 1/5

Our framework rates PLTR as a Neutral to light-underweight candidate at the current price, with any long exposure better treated as a momentum-quality position rather than a value allocation. The stock is suitable only if the portfolio can tolerate high multiple compression risk, because the market is capitalizing the company at 255.3x earnings and 86.0x sales while the DCF base case is only $76.54. On a risk-budget basis, that means sizing should be modest unless the team has exceptionally high confidence in sustained >40% growth and durable margins.

Entry criteria: we would want either a pullback toward the DCF base value area, or evidence that the business is re-accelerating without incremental dilution. Exit criteria: if revenue growth decelerates materially from +56.2%, if FCF margin falls well below 46.9%, or if valuation expands further without fundamental revision. This does pass a limited circle of competence test: the economics are visible and the balance sheet is simple, but the end-market mix, customer concentration, and long-run contract durability remain partly in the spine, so conviction should remain capped until those gaps narrow.

Conviction is positive, but not high enough to justify aggressive sizing at the current quote. The score reflects a strong operating business with clear cash generation, offset by valuation that already discounts an unusually optimistic future. Weighted total: 6.4/10.

• Business quality — score 9/10, weight 25%, evidence quality A: audited 2025 gross margin 82.4% and FCF margin 46.9%.
• Growth durability — score 7/10, weight 25%, evidence quality A-/B+: computed revenue growth +56.2% but forward mix details are .
• Balance-sheet resilience — score 10/10, weight 15%, evidence quality A: current ratio 7.11, debt/equity 0.0, liabilities/equity 0.19.
• Valuation attractiveness — score 2/10, weight 25%, evidence quality A: P/E 255.3, P/S 86.0, DCF fair value $76.54.
• Model confidence / data completeness — score 5/10, weight 10%, evidence quality B: strong audited data, but segment/customer mix and guidance are missing.

Interpretation: the company deserves a premium for quality, but the current equity price already assumes the strongest parts of the story continue for years. That keeps conviction in the single-digit middle range rather than at a true high-conviction level.

Palantir appears to be in the Acceleration phase of its business cycle, but with an important caveat: the company is no longer a pure growth story, because 2025 audited results show $1.41B of operating income and $2.10B of free cash flow. That combination suggests the business has moved beyond early product-market fit into a scale phase where operating leverage and cash conversion are visible in reported numbers.

The evidence for acceleration is the +56.2% revenue growth rate, paired with an 82.4% gross margin and 31.6% operating margin. Those economics are not typical for a high-growth company still trying to prove its model; they look more like a premium software platform entering a self-funding expansion cycle. At the same time, the current valuation at 86.0x sales and 255.3x earnings means the equity is being priced as though this acceleration can persist for a long time, leaving little room for a normal deceleration.

In cycle terms, this is not a maturity profile yet, because the market is still underwriting further expansion in revenue per share from $1.85 estimated for 2025 to $2.55 estimated for 2026. But it is also not an early-stage story: the balance sheet already shows $7.39B of shareholders’ equity and only $1.41B of liabilities, which is consistent with a company that has crossed the point where capital scarcity constrains strategy.

Palantir’s recurring pattern is that it appears willing to invest aggressively in product and then monetize that investment through sharply improving operating leverage once adoption broadens. In 2025, the company spent $557.7M on R&D, equal to 12.5% of revenue, yet still produced 31.6% operating margins and 46.9% free cash flow margin. That pattern is important because it suggests management is not optimizing for short-term margin maximums; it is trying to preserve technical depth while letting scale do the work.

The other repeated pattern is a conservative capital structure. Total liabilities were only $1.41B against $7.39B of equity at year-end 2025, while the current ratio was 7.11 and debt-to-equity was 0.0. That means the company has historically avoided the kind of balance-sheet stress that forces strategic compromise in downturns. Instead, the operating pattern appears to be: invest in core product capability, maintain high liquidity, and allow revenue growth to translate into equity compounding.

A final recurring feature is modest but persistent dilution pressure. Shares outstanding moved from 2.37B at 2025-06-30 to 2.39B at 2025-12-31, with diluted shares at 2.57B. Historically, that means per-share upside must outgrow issuance and stock-based compensation effects; otherwise, headline growth can outpace per-share value creation.

Palantir’s management profile, judged strictly from audited operating outcomes, looks unusually strong for a software platform company. In 2025, the business delivered $3.69B of gross profit, $1.41B of operating income, and $1.63B of net income on +56.2% revenue growth, while holding gross margin at 82.4% and operating margin at 31.6%. Those numbers indicate leadership is scaling the franchise without sacrificing pricing power or cost discipline. That is the hallmark of a team building captivity and barriers, because customers appear to be adopting more deeply even as the company expands.

The cash profile strengthens the case. Free cash flow reached $2.10B in 2025 against CapEx of only $33.9M, which means management is not relying on heavy capital intensity to grow. At the same time, R&D expense remained material at $557.7M or 12.5% of revenue, so the company is still investing in product breadth and technical differentiation. The main caveat is dilution: SBC was 15.3% of revenue and diluted shares reached 2.57B at year-end. Overall, leadership appears to be compounding competitive advantage, but it must keep per-share discipline tight for the market to accept the premium valuation.

Governance quality cannot be assessed with high confidence because the provided spine does not include board composition, director independence, committee structure, dual-class details, or shareholder-rights provisions from a DEF 14A or charter documents. As a result, the strongest evidence available is indirect: the balance sheet remains conservative, with $7.39B of shareholders’ equity and only $1.41B of total liabilities at 2025 year-end, so management is not using leverage to obscure poor governance outcomes.

From a shareholder-rights perspective, the absence of disclosed proxy data is a real limitation. For a company valued at $384.68B with a P/E of 255.3 and P/S of 86.0, board oversight and incentive design matter more than usual because a single governance misstep can be expensive at this multiple. Based on the available facts, governance is best treated as unverified rather than positive or negative.

There is not enough disclosed proxy information in the data spine to evaluate the exact mix of base pay, bonus, equity grants, performance metrics, or clawback provisions. That means compensation alignment must be inferred from outcomes rather than documented design. The strongest inference available is that management has been rewarded in a setting where the company generated $2.10B of free cash flow, $1.63B of net income, and 31.6% operating margin in 2025.

Still, the incentive problem is not trivial. Stock-based compensation was 15.3% of revenue, and diluted shares were 2.57B at year-end versus 2.56B at 2025-09-30. That does not prove misalignment, but it does mean the compensation system is already large enough to affect per-share returns. In a stock priced at $160.84, investors need explicit evidence that equity awards are tied to durable per-share value creation, not just absolute growth.

The provided data spine does not include insider ownership percentages, Form 4 transactions, or recent buy/sell activity, so there is no EDGAR-backed basis to claim insider buying or selling trends. That is important because Palantir’s valuation is elevated at $137.97 per share and $384.68B market cap; in names like this, insider signals often matter more than in lower-multiple software peers.

What we can say is that dilution is visible in the share data: diluted shares were 2.56B at 2025-09-30 and 2.57B at 2025-12-31, while shares outstanding were 2.39B at year-end. That does not establish insider selling, but it does reinforce that equity issuance/compensation remains relevant to per-share economics. Until proxy and Form 4 data are available, insider alignment should be treated as unverified.

Based on the provided spine, Palantir’s shareholder-rights profile cannot be fully validated because the filing-level governance details needed to confirm poison pill status, board classification, voting standard, proxy access, dual-class structure, and shareholder proposal history are not present. That missing disclosure matters because the stock’s valuation is extremely high, with a P/E of 255.3 and EV/Revenue of 85.6, so investors should care about whether minority shareholders have meaningful structural protections.

What can be said with confidence is that the report is currently incomplete rather than clearly shareholder-friendly. Without a DEF 14A excerpt, the right conclusion is conservative: on poison pill, classified board, dual-class shares, majority vs. plurality voting, proxy access, and proposal history. In a company valued at $384.68B, governance transparency itself becomes part of the equity story, because the market is underwriting sustained execution without being shown the full set of control mechanics.

Accounting quality looks solid on the metrics available from the audited spine. Palantir generated $2.10B of free cash flow on $1.63B of net income in 2025, with operating cash flow of $2.13B and a free cash flow margin of 46.9%. That is the kind of cash conversion that usually supports a “clean” flag rather than a watchlist flag, especially with a current ratio of 7.11, debt-to-equity of 0.0, and total liabilities to equity of 0.19.

The main nuance is stock-based compensation. SBC is 15.3% of revenue, which is meaningful and can make per-share economics less attractive than headline margins suggest. Revenue recognition policy, auditor continuity, off-balance-sheet items, and related-party transactions are not provided in the spine, so they remain . Even so, the available evidence points to strong earnings quality, limited balance-sheet risk, and only moderate accounting caution around dilution and non-cash compensation.

Palantir appears to be in the Acceleration phase of its business cycle, but with an important caveat: the company is no longer a pure growth story, because 2025 audited results show $1.41B of operating income and $2.10B of free cash flow. That combination suggests the business has moved beyond early product-market fit into a scale phase where operating leverage and cash conversion are visible in reported numbers.

The evidence for acceleration is the +56.2% revenue growth rate, paired with an 82.4% gross margin and 31.6% operating margin. Those economics are not typical for a high-growth company still trying to prove its model; they look more like a premium software platform entering a self-funding expansion cycle. At the same time, the current valuation at 86.0x sales and 255.3x earnings means the equity is being priced as though this acceleration can persist for a long time, leaving little room for a normal deceleration.

In cycle terms, this is not a maturity profile yet, because the market is still underwriting further expansion in revenue per share from $1.85 estimated for 2025 to $2.55 estimated for 2026. But it is also not an early-stage story: the balance sheet already shows $7.39B of shareholders’ equity and only $1.41B of liabilities, which is consistent with a company that has crossed the point where capital scarcity constrains strategy.

Palantir’s recurring pattern is that it appears willing to invest aggressively in product and then monetize that investment through sharply improving operating leverage once adoption broadens. In 2025, the company spent $557.7M on R&D, equal to 12.5% of revenue, yet still produced 31.6% operating margins and 46.9% free cash flow margin. That pattern is important because it suggests management is not optimizing for short-term margin maximums; it is trying to preserve technical depth while letting scale do the work.

The other repeated pattern is a conservative capital structure. Total liabilities were only $1.41B against $7.39B of equity at year-end 2025, while the current ratio was 7.11 and debt-to-equity was 0.0. That means the company has historically avoided the kind of balance-sheet stress that forces strategic compromise in downturns. Instead, the operating pattern appears to be: invest in core product capability, maintain high liquidity, and allow revenue growth to translate into equity compounding.

A final recurring feature is modest but persistent dilution pressure. Shares outstanding moved from 2.37B at 2025-06-30 to 2.39B at 2025-12-31, with diluted shares at 2.57B. Historically, that means per-share upside must outgrow issuance and stock-based compensation effects; otherwise, headline growth can outpace per-share value creation.